Survival in esophageal high-grade dysplasia/adenocarcinoma post endoscopic resection

Digestive and Liver Disease

Volumn 45, Issue 12, 2013, Pages 1028-1033

  Qumseya, Bashar J ^a   Panossian, Abraham M ^a   Rizk, Cynthia ^a   Cangemi, David J ^a   Wolfsen, Christianne ^a   Raimondo, Massimo ^a   Woodward, Timothy A ^a   Wallace, Michael B ^a   Wolfsen, Herbert C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Barrett oesophagus; Endoscopic resection; Esophageal adenocarcinoma; Longterm survival

Indexed keywords

AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

BARRETT OESOPHAGUS; ENDOSCOPIC RESECTION; ESOPHAGEAL ADENOCARCINOMA; LONGTERM SURVIVAL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL STENOSIS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84887182711     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.06.009     Document Type: Article

References (37)

1. Vizcaino A.P., Moreno V., Lambert R., et al. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. International Journal of Cancer 2002, 99:860-868.
2. Pohl H., Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. Journal of the National Cancer Institute 2005, 97:142-146.
3. Sharma P., Falk G.W., Weston A.P., et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clinical Gastroenterology and Hepatology 2006, 4:566-572.
4. Cameron A.J., Carpenter H.A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. American Journal of Gastroenterology 1997, 92:586-591.
5. Incarbone R., Bonavina L., Saino G., et al. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surgical Endoscopy 2002, 16:263-266.
6. Ferguson M.K., Durkin A. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. Journal of Gastrointestinal Surgery 2002, 6:29-35. discussion 6.
7. Fountoulakis A., Zafirellis K.D., Dolan K., et al. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. British Journal of Surgery 2004, 91:997-1003.
8. Cooper S.C., El-agib A., Dar S., et al. Endoscopic surveillance for Barrett's oesophagus: the patients' perspective. European Journal of Gastroenterology & Hepatology 2009, 21:850-854.
9. Wang K.K., Sampliner R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. American Journal of Gastroenterology 2008, 103:788-797.
10. Hirota W.K., Zuckerman M.J., Adler D.G., et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointestinal Endoscopy 2006, 63:570-580.
11. American gastroenterological association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011, 140:1084-1091.
12. Falk G.W., Ours T.M., Richter J.E. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointestinal Endoscopy 2000, 52:197-203.
13. Konda V.J., Ross A.S., Ferguson M.K., et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated. Clinical Gastroenterology and Hepatology 2008, 6:159-164.
14. Edwards M.J., Gable D.R., Lentsch A.B., et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Annals of Surgery 1996, 223:585-589. discussion 9-91.
15. Heitmiller R.F., Redmond M., Hamilton S.R. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Annals of Surgery 1996, 224:66-71.
16. Rusch V.W., Levine D.S., Haggitt R., et al. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer 1994, 74:1225-1229.
17. Clark G.W., DeMeester T.R. Surgical management of Barrett's esophagus. Annales chirurgiae et gynaecologiae 1995, 84:139-144.
18. Holscher A.H., Bollschweiler E., Schneider P.M., et al. Early adenocarcinoma in Barrett's oesophagus. British Journal of Surgery 1997, 84:1470-1473.
19. Pera M., Trastek V.F., Carpenter H.A., et al. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy. Annals of Thoracic Surgery 1992, 54:199-204.
20. Namasivayam V., Wang K.K., Prasad G.A. Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions. Clinical Gastroenterology and Hepatology 2010, 8:743-754. [quiz e96].
21. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000, 118:670-677.
22. Larghi A., Lightdale C.J., Ross A.S., et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 2007, 39:1086-1091.
23. Moss A., Bourke M.J., Hourigan L.F., et al. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. American Journal of Gastroenterology 2010, 105:1276-1283.
24. Pech O., Bollschweiler E., Manner H., et al. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery 2011, 254:67-72.
25. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointestinal Endoscopy 2007, 65:3-10.
26. Sampliner R.E. Endoscopic therapy for Barrett's esophagus. Clinical Gastroenterology and Hepatology 2009, 7:716-720.
27. Shaheen N., Wang K., Wolfsen H., et al. Durability of reversion to neosquamous epithelium following radiofrequency ablation for dysplastic BE: long term follow-up of the AIM Dysplasia trial. Gastroenterology 2011, 140:S-179.
28. Wolfsen H.C. Endoluminal therapy for Barrett's esophagus. Gastrointestinal Endoscopy Clinics of North America 2007, 17:59-82. vi-vii.
29. Gross S.A., Wolfsen H.C. The role of photodynamic therapy in the esophagus. Gastrointestinal Endoscopy Clinics of North America 2010, 20:35-53. vi.
30. Wolfsen H.C., Hemminger L.L., Wallace M.B., et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Alimentary Pharmacology & Therapeutics 2004, 20:1125-1131.
31. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. New England Journal of Medicine 2009, 360:2277-2288.
32. Panossian A.M., Raimondo M., Wolfsen H.C. State of the art in the endoscopic imaging and ablation of Barrett's esophagus. Digestive and Liver Disease 2011, 43(May):365-373.
33. Wolfsen H.C. Endoscopic ablation therapy: imaging and advanced technology in action. Gastroenterology 2009, 137:1225-1228.
34. Greenwald B., Dumot J., Abrams J., et al. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy (Abstract W1352). Gastrointestinal Endoscopy 2009, 69:AB349.
35. Prasad G.A., Wang K.K., Buttar N.S., et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007, 132:1226-1233. [Research Support, N.I.H., Extramural].
36. Raja S., Rice T.W., Goldblum J.R., et al. Esophageal submucosa: The watershed for esophageal cancer. J Thorac Cardiovasc Surg 2011, 142:1403-1411. e1.
37. Lee P.C., Port J.L., Paul S., et al. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Annals of Thoracic Surgery 2009, 88:186-193.